As a patent agent and technical advisor at the Chicago office of Hahn Loeser, Dr. Jacquiau assists in all aspects of the firm’s patent practice, including patent prosecution and litigation. He utilizes his scientific and patent agent background across a variety of technologies, particularly in bioengineering, biochemistry, molecular biology and microbiology.
Dr. Jacquiau received his Ph.D. from the University of Cambridge after investigating the genetic and biochemical features responsible for the biodegradation of toxic pollutants. Dr. Jacquiau earned a Master of Science in bioreactor systems after studying chemical engineering, biotechnology, genetics, fermentation optimization and kinetics, as well as upstream and downstream processes. As an undergraduate, he studied both biological sciences and the food and biological industries.
At Hahn Loeser
Dr. Jacquiau developed novel genetic tools for the creation of biosensors and became co-inventor on a U.S. patent. His work also contributed to the creation of a biotechnology company that specializes in developing biosensors for the detection and removal of environmental contaminants. Additionally, Dr. Jacquiau investigated various mechanisms that regulate cellular sensitivity or resistance to anti-cancer agents. He researched DNA rearrangements affecting cell-cycle regulation and highlighted the role of various mechanisms of protein degradation in modulating cellular response to enzyme inhibitors that are commonly used in the treatment of childhood cancer.
Dr. Jacquiau previously worked at the Lankenau Institute for Medical Research in Wynnewood, Pennsylvania, where he first developed antibodies to be used in cancer diagnostics, or research tools to validate biomarkers of breast and ovarian cancer. At the institute, Dr. Jacquiau evaluated scientific innovations and business proposals and subsequently became a business and scientific funding associate in the Department of Business Development. He contributed to the creation of a novel drug screening facility for drug target validation and drug discovery, as well as a center for the production of human antibodies to be used as medical diagnostics, or as novel therapeutics. He also collaborated with surgeons and clinicians to develop protocols for clinical trials and wrote proposals to attract funding and to promote scientific collaborations.
A Few Clients
- Pharmaceutical companies and Research Institutions
- Patents – Biosensor Materials and Methods (co-inventor), United States Patent Approved (US 6,849,442 B1), Feb. 1, 2005
University of Cambridge (UK), Ph.D., Department of Genetics, 2000. Honors and activities: Marie Curie Research Fellowship, recipient; Industrial Case Studentship, Biotechnology & Biological Sciences Research Counsel, recipient
University of Manchester Institute of Science and Technology, M.S. in bioreactor systems, 1995. Honors and activities: Goodwill Ambassadorial Scholarship of the Rotary International, recipient
Manchester Metropolitan University, B.S. in applied biology, 1994
Paris XII University, University Institute of Technology, D.U.T. in Food and Biological Industries, 1992
American Association for Cancer Research: member
American Intellectual Property Law Association: member
The American Society for Microbiology: member
The Genetics Society of America: member
Intellectual Property Law Association of Chicago: member
Marie Curie European Research Fellowship Association: member
Phi Alpha Delta Law Fraternity: member
University of Cambridge Alumni Association: member
University of Manchester/UMIST Alumni Association: member
U.S. Patent and Trademark Office (Registration Number: 64976)